📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

Utilizing Immunocytokines for Cancer Therapy (2021)

First Author: Runbeck E

Attributed to: Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/antib10010010

PubMed Identifier: 33803078

Publication URI: http://europepmc.org/abstract/MED/33803078

Type: Journal Article/Review

Parent Publication: Antibodies

Issue: 1

ISSN: 2073-4468